Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06723626
NA

Effects of Intravenous Metabolic Recovery Agent in Elderly Septic Patients on Prognosis and Microcirculation.

Sponsor: Southeast University, China

View on ClinicalTrials.gov

Summary

This study intends to observe the effect of intravenous hydrocortisone combined with vitamin C and vitamin B1 infusion on the prognosis and sublingual microcirculation in patients with sepsis or septic shock through a prospective randomized controlled study method.

Official title: Clinical Study of the Effect of Intravenous Hydrocortisone Combined With Vitamin C and Vitamin B1 Infusion on Prognosis and Sublingual Microcirculation in Elderly Patients With Sepsis or Septic Shock.

Key Details

Gender

All

Age Range

60 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2024-07-01

Completion Date

2025-11-30

Last Updated

2025-03-14

Healthy Volunteers

No

Conditions

Interventions

DRUG

Metabolic resuscitation agent

Intervention group will receive intravenous hydrocortisone (200mg every 24 hours), vitamin C (1.5g every 6 hours), and thiamine (200 mg every 12 hours).

DRUG

Hydrocortisone

Placebo group will receive intravenous hydrocortisone 200mg every 24 hours.

Locations (1)

Zhongda Hospital Southeast University

Nanjing, Jiangsu, China